Open AccessCurcumin and natural derivatives inhibit Ebola viral proteins: An In silico approach
Author(s) -
Shruti Baikerikar
Publication year - 2017
Publication title -
pharmacognosy research
Language(s) - English
Resource type - Journals
eISSN - 0976-4836
pISSN - 0974-8490
DOI - 10.4103/pr.pr_30_17
Subject(s) - curcumin , ebola virus , chemistry , metabolite , docking (animal) , ebolavirus , secondary metabolite , pharmacology , biochemistry , virology , virus , biology , medicine , nursing , gene
Ebola viral disease is a severe and mostly fatal disease in humans caused by Ebola virus. This virus belongs to family Filoviridae and is a single-stranded negative-sense virus. There is no single treatment for this disease which puts forth the need to identify new therapy to control and treat this fatal condition. Curcumin, one of the bioactives of turmeric, has proven antiviral property.